ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Oct 29, 2021 10:19 JST
Source:
Mitsubishi Heavy Industries, Ltd.
MHI Invests in Cemvita Factory, Inc., a Leading Industrial Biotechnology Startup, to Accelerate Decarbonization Efforts
The partnership contributes to MHI's strategic focus on identifying and accelerating decarbonization opportunities through investments in renewable projects and climate tech startups
TOKYO, Oct 29, 2021 - (JCN Newswire) - Mitsubishi Heavy Industries (MHI) Group today announced that it has invested in Cemvita Factory, Inc. (Cemvita), a Houston-based startup that utilizes innovative synthetic biology to decarbonize heavy industries such as chemical manufacturing, mining, and oil and gas. By investing in Cemvita's business expansion, MHI continues to deliver on its strategy to identify and accelerate decarbonization opportunities through investments in renewable projects and climate tech startups.
MHI Group is committed to building an innovative solutions ecosystem to realize a carbon-neutral future. This includes strengthening its decarbonization technology offerings and developing a carbon dioxide (CO2) ecosystem that is central to those initiatives. Carbon capture, utilization and storage solutions are increasingly viewed as effective means to realizing a carbon-neutral society, and Cemvita's technology is one of many solutions needed to achieve it.
"At MHI we are committed to accelerating decarbonization. We believe there is not only one technology to be utilized, but that it is necessary to combine multiple technologies to achieve our world's carbon net-zero goals," said Yoshihiro Shiraiwa, President and CEO of Mitsubishi Heavy Industries America. "We must work closely with new and existing partners to develop new business models that advance our goals for decarbonization."
Cemvita provides innovative CO2 utilization solutions through biotechnology for heavy industries. Its bio-manufacturing platform mitigates emissions from traditionally energy-intensive chemical and catalytic conversion processes by operating under ambient temperature and pressure. Additionally, this same technology can turn polymer production into a low-carbon activity by utilizing CO2 as a feedstock, a crucial step in building a circular carbon economy.
"We are excited to have Cemvita supported by strong corporate partners like MHI, who has extensive engineering capabilities across heavy industry markets," said Cemvita Factory Co-Founder and CEO Moji Karimi. "This capital will accelerate our growth and scale our carbon negative solutions to fight climate change."
The investment has been executed through Mitsubishi Heavy Industries America, Inc. MHI joins a consortium of investors, including Energy Capital Ventures and Sumitomo Corporation of America.
About Cemvita Factory, Inc.
Cemvita Factory, Inc, is on a mission to reverse climate change by leveraging synthetic biology. This is done by leveraging the biomimicry of natural processes to sustainably produce chemicals and polymers. Additionally, Cemvita's synthetic biology platform is used to develop and optimize low carbon bioprocesses for heavy industry such as mining and oil and gas. Visit www.cemvitafactory.com for more information.
About MHI Group
Mitsubishi Heavy Industries (MHI) Group is one of the world's leading industrial groups, spanning energy, logistics & infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on www.spectra.mhi.com.
Source: Mitsubishi Heavy Industries, Ltd.
Sectors: Energy, Alternatives, Alternative Energy
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST
NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST
Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST
Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST
ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST
Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST
Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST
Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST
Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST
NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST
Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST
CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 18, 2024 23:30 JST
World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
Nov 18, 2024 17:29 JST
Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business
Nov 18, 2024 12:31 JST
Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round
Nov 18, 2024 09:25 JST
COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding
Nov 16, 2024 18:00 JST
Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki
Nov 15, 2024 18:58 JST
Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)
Nov 15, 2024 17:33 JST
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
Nov 15, 2024 14:31 JST
Resorttrust Group and Mitsubishi Corporation Launch Joint Study in Medical Tourism
Nov 15, 2024 12:32 JST
More Latest Release >>
Related Release
Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
11/20/2024 3:30:00 PM JST
Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki
11/15/2024 6:58:00 PM JST
MHI Publishes MHI REPORT 2024
11/13/2024 4:52:00 PM JST
Mitsubishi Heavy Industries Continues Order Intake, Revenue, and Profit Growth in Strong First Half, Raises Full-Year Order Intake Guidance
11/5/2024 2:37:00 PM JST
Mitsubishi Power Receives Order for Facility Retrofit at the Darajat Geothermal Power Plant in Indonesia
10/28/2024 3:35:00 PM JST
MHI-MME Licenses Manufacturing and Sale of MET Turbochargers to Leading Chinese Marine Machinery Manufacturer
10/25/2024 2:15:00 PM JST
MHI Receives Order to Supply MOX Fuel Assemblies for Unit 3 of Genkai Nuclear Power Station, Kyushu Electric Power Co. Inc.
10/18/2024 10:59:00 PM JST
MHI Thermal Systems Receives Order for Large-scale Centrifugal Chillers from Empower for its District Cooling Plants in Dubai, UAE
10/18/2024 11:20:00 AM JST
Orders for Gas Turbines through Partner Firm in China Reaches 150 Units
10/16/2024 7:50:00 PM JST
Mitsubishi Heavy Industries Invests in Koloma, a US-Based Geologic Hydrogen Exploration Startup
10/16/2024 9:03:00 AM JST
More Press release >>